DK0535129T3 - Et antikoagulerende præparat - Google Patents

Et antikoagulerende præparat

Info

Publication number
DK0535129T3
DK0535129T3 DK91912208.5T DK91912208T DK0535129T3 DK 0535129 T3 DK0535129 T3 DK 0535129T3 DK 91912208 T DK91912208 T DK 91912208T DK 0535129 T3 DK0535129 T3 DK 0535129T3
Authority
DK
Denmark
Prior art keywords
epi
increase
anticoagulant
mucopolysaccharide
prophylaxis
Prior art date
Application number
DK91912208.5T
Other languages
English (en)
Inventor
Ole Juul Nordfang
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of DK0535129T3 publication Critical patent/DK0535129T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Materials For Medical Uses (AREA)
DK91912208.5T 1990-06-19 1991-05-30 Et antikoagulerende præparat DK0535129T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Publications (1)

Publication Number Publication Date
DK0535129T3 true DK0535129T3 (da) 1995-08-07

Family

ID=8105367

Family Applications (2)

Application Number Title Priority Date Filing Date
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat
DK91912208.5T DK0535129T3 (da) 1990-06-19 1991-05-30 Et antikoagulerende præparat

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK148890A DK148890D0 (da) 1990-06-19 1990-06-19 Farmaceutisk praeparat

Country Status (11)

Country Link
EP (1) EP0535129B1 (da)
JP (1) JP3362038B2 (da)
AT (1) ATE119781T1 (da)
AU (1) AU645581B2 (da)
BG (1) BG61181B1 (da)
CA (1) CA2085101A1 (da)
DE (1) DE69108242T2 (da)
DK (2) DK148890D0 (da)
ES (1) ES2069894T3 (da)
HU (1) HU221323B1 (da)
WO (1) WO1991019514A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849703A (en) * 1990-08-27 1998-12-15 G. D. Searle & Co. Pre-formed anticoagulant heparin/TFPI complexes
US6291427B1 (en) 1990-08-27 2001-09-18 G.D. Searle & Co. Anticoagulant combination of LACI and sulfated polysaccharides
DK261490D0 (da) * 1990-10-31 1990-10-31 Novo Nordisk As New pharmaceutical compound
US5276015A (en) * 1992-03-18 1994-01-04 Washington University Method of inhibiting microvascular thrombosis
US20030171292A1 (en) 1992-06-01 2003-09-11 Creasey Abla A. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
US6063764A (en) * 1992-06-01 2000-05-16 Washington University & Chiron Corp. Method for using lipoprotein associated coagulation inhibitor to treat sepsis
KR950701820A (ko) * 1992-06-11 1995-05-17 로저 에이. 윌리암스 패혈증 및 패혈증-연관 옹고장애의 예방 및 치료(prophylaxs and treatment of sepsis and sepsis-associated coagulation disorders)
ZA941414B (en) * 1993-03-02 1994-09-28 Novo Nordisk A G Non-glycosylated TFPI analogues
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
PL372138A1 (en) 2001-10-15 2005-07-11 Chiron Corporation Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3170001D1 (en) * 1980-09-30 1985-05-23 Bayer Ag Method for the production of an antithrombin-heparin complex and pharmaceutical compositions containing the complex
US4689323A (en) * 1983-09-26 1987-08-25 Miles Laboratories, Inc. Covalently bound heparin--antithrombin-III complex
IL79255A0 (en) * 1986-06-26 1986-09-30 Hadassah Med Org Composition for metastasis prevention
US4900723A (en) * 1988-04-29 1990-02-13 E. R. Squibb & Sons, Inc. Method of preventing or reducing venous thrombosis using a thromboxane A2 receptor antagonist in conjunction with heparin and combination
DK408089D0 (da) * 1989-08-18 1989-08-18 Novo Nordisk As Proteiner

Also Published As

Publication number Publication date
WO1991019514A1 (en) 1991-12-26
DE69108242T2 (de) 1995-07-06
DE69108242D1 (de) 1995-04-20
AU645581B2 (en) 1994-01-20
ES2069894T3 (es) 1995-05-16
EP0535129A1 (en) 1993-04-07
ATE119781T1 (de) 1995-04-15
BG61181B1 (bg) 1997-02-28
HUT63578A (en) 1993-09-28
EP0535129B1 (en) 1995-03-15
HU221323B1 (en) 2002-09-28
JP3362038B2 (ja) 2003-01-07
HU9204036D0 (en) 1993-03-29
AU8060491A (en) 1992-01-07
DK148890D0 (da) 1990-06-19
CA2085101A1 (en) 1991-12-20
JPH05507926A (ja) 1993-11-11

Similar Documents

Publication Publication Date Title
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
FI931097A0 (fi) Laekemedel, deras framstaellning och anvaendning vid bekaempning av smaertor och/eller inflammationen hos maenniskor och djur
ES2119411T5 (es) Combinaciones de proteinas y anticoagulantes tromboliticamente activos, y usos de los mismos.
DK0535129T3 (da) Et antikoagulerende præparat
EA200400548A1 (ru) Лечение тяжёлой пневмонии путём введения ингибитора пути тканевого фактора (tfpi)
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ES2168766T3 (es) Preparacion farmaceutica que incluye el propeptido vwf.
DE69734450D1 (de) Photopherese-behandlung von hcv-infektionen
SE9002550D0 (sv) Heparinfragment
ES2055902T3 (es) Composiciones farmaceuticas de proteinas activadoras del plasminogeno.
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
ES2055314T3 (es) Tratamiento de disfuncion leucocitaria con gm-csf.
ES2058343T3 (es) Piridinas disubstituidas.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
DK0651654T3 (da) Anvendelse af lysozymdimer til fremstilling af et lægemiddel til styrkelse af de naturlige forsvarsmekanismer
DK225689A (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
SE9303612D0 (sv) New use
RU92016457A (ru) Антикоагулирующий препарат
EP0340933A3 (en) Heparin-containing formulations
SE9003181D0 (sv) Use of heparin fraction
DE69128465D1 (de) Heparinneutralisierung durch blutplättchenfaktor
EA200400817A1 (ru) Идрапаринукс для лечения и вторичной профилактики случаев венозной тромбоэмболии у пациентов с тромбозом глубоких вен
Burrows After-Results of Treatment of Severe Lupus with Finsen Light (8 Cases)
Forman Verrucose Dermatitis of Amputation Stump
UA7180C2 (uk) Препарат для лікування та профілактики атерогенних дисліпопротеїнемій та синдрому гіперкоагуляції